Yuichiro Maekawa Selected Research

Catecholamines

2/2019	Apical Takotsubo syndrome versus anterior acute myocardial infarction: findings from the Tokyo Cardiovascular Care Unit network registry.
12/2016	Predictive Value of QRS Duration at Admission for In-Hospital Clinical Outcome of Takotsubo Cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichiro Maekawa Research Topics

Disease

24	Myocardial Infarction 09/2022 - 01/2003
20	Heart Failure 08/2022 - 01/2004
11	Acute Coronary Syndrome 11/2023 - 11/2011
9	Fibrosis (Cirrhosis) 08/2019 - 10/2004
8	Hemorrhage 12/2023 - 10/2013
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 09/2012
8	Ventricular Remodeling 08/2019 - 04/2003
7	Thrombosis (Thrombus) 12/2023 - 02/2004
7	ST Elevation Myocardial Infarction 01/2020 - 11/2009
6	Atrial Fibrillation 02/2023 - 06/2020
6	Infarction (Infarctions) 06/2017 - 01/2003
5	Hypertension (High Blood Pressure) 01/2019 - 02/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 06/2016 - 05/2010
4	Hypertrophy 03/2022 - 08/2007
4	Unstable Angina 10/2020 - 09/2002
4	Ischemia 11/2018 - 11/2013
4	Inflammation (Inflammations) 08/2011 - 03/2008
4	Heart Rupture 12/2010 - 01/2003
3	Ventricular Tachycardia 09/2022 - 11/2009
3	Atherosclerosis 07/2022 - 08/2016
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 04/2022 - 01/2018
3	Cardiomegaly (Heart Hypertrophy) 03/2022 - 03/2008
3	Insulin Resistance 07/2019 - 01/2011
3	Aneurysm (Aneurysms) 01/2018 - 07/2011
3	Pulmonary Hypertension 09/2017 - 04/2015
3	Shock 12/2016 - 01/2015
3	Acute Kidney Injury (Acute Renal Failure) 04/2016 - 10/2013
3	Aortic Dissection 02/2015 - 06/2005
3	Abdominal Aortic Aneurysm 10/2011 - 07/2011
3	Obesity 08/2011 - 08/2007
3	Necrosis 08/2011 - 02/2009
3	Death (Near-Death Experience) 12/2010 - 02/2009
2	Cardiogenic Shock 02/2024 - 01/2016
2	Amyloidosis 08/2023 - 01/2023
2	Diabetes Mellitus 02/2023 - 12/2017
2	Atrioventricular Block 01/2023 - 01/2021
2	Chronic Renal Insufficiency 12/2022 - 01/2017
2	Hypercholesterolemia 07/2022 - 01/2022
2	Rheumatoid Arthritis 03/2022 - 03/2019
2	Left Ventricular Dysfunction 03/2022 - 12/2010
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2022 - 01/2018
2	Pulmonary Embolism 12/2021 - 11/2010
2	Ventricular Fibrillation 10/2021 - 11/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 08/2011
2	Heart Arrest (Cardiac Arrest) 01/2017 - 10/2012
2	Hypoxia (Hypoxemia) 01/2017 - 04/2009
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2016 - 01/2007
2	Aortic Valve Stenosis (Aortic Stenosis) 05/2014 - 09/2012
1	Malnutrition (Nutritional Deficiencies) 11/2023
1	Cardiomyopathies (Cardiomyopathy) 08/2023
1	Bacterial Infections (Bacterial Infection) 05/2023

Drug/Important Bio-Agent (IBA)

14	C-Reactive ProteinIBA 02/2019 - 01/2003
5	CytokinesIBA 03/2012 - 04/2003
5	Messenger RNA (mRNA)IBA 08/2011 - 10/2004
4	Oxygen (Dioxygen)IBA 08/2023 - 01/2017
3	Clopidogrel (Plavix)FDA Link 12/2023 - 06/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2023 - 08/2016
3	Tolvaptan FDA Link 08/2022 - 01/2019
3	omega-Chloroacetophenone (Mace)IBA 10/2020 - 05/2010
3	Glucose (Dextrose)FDA LinkGeneric 07/2019 - 01/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2019 - 05/2010
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2009
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 08/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012 - 01/2011
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2011 - 10/2008
2	Technetium Tc 99m PyrophosphateIBA 08/2023 - 01/2023
2	Prealbumin (Transthyretin)IBA 08/2023 - 01/2023
2	FibrinIBA 05/2023 - 04/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023 - 07/2011
2	Cytochrome P-450 CYP3AIBA 08/2022 - 04/2020
2	CholesterolIBA 07/2022 - 08/2016
2	AA amyloidosisIBA 03/2022 - 05/2014
2	tocilizumab (atlizumab)FDA Link 03/2022 - 05/2014
2	Amyloid (Amyloid Fibrils)IBA 03/2022 - 08/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2021 - 02/2019
2	Everolimus FDA Link 10/2020 - 08/2016
2	CatecholaminesIBA 02/2019 - 12/2016
2	Mitochondrial Permeability Transition PoreIBA 11/2018 - 12/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 12/2017
2	Trinitrotoluene (TNT)IBA 01/2017 - 01/2014
2	EnzymesIBA 10/2011 - 01/2011
2	Collagen Type I (Type I Collagen)IBA 01/2011 - 10/2004
2	NF-kappa B (NF-kB)IBA 10/2009 - 03/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2008 - 02/2005
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2008 - 10/2004
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2008 - 01/2004
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2008 - 10/2004
2	CollagenIBA 02/2005 - 10/2004
1	LDL CholesterolIBA 05/2023

Therapy/Procedure

24	Percutaneous Coronary Intervention 02/2024 - 11/2009
20	Therapeutics 05/2023 - 09/2002
9	Stents 12/2023 - 02/2005
3	Ligation 01/2022 - 03/2012
3	Transcatheter Aortic Valve Replacement 01/2017 - 04/2016
2	Drug-Eluting Stents 12/2023 - 11/2011
2	Catheters 01/2023 - 01/2021
2	Catheter Ablation 09/2022 - 01/2022
2	Thrombectomy 12/2021 - 05/2019
2	Punctures 04/2021 - 01/2016
2	Secondary Prevention 01/2020 - 01/2020